Literature DB >> 31420620

[Evaluating inferior vena cava wall invasion in renal cell carcinoma tumor thrombus with MRI].

J Y Wu1, Y Mi2, S Liu1, L Yao2, Q Tang2, Z S He2, X Y Wang1.   

Abstract

OBJECTIVE: To evaluate the diagnostic performance of MRI for the assessment of inferior vena cava (IVC) wall invasion by IVC thrombus in patients with renal cell carcinoma (RCC).
METHODS: We retrospectively collected patients who underwent radical nephrectomy and thrombectomy for RCC between 2010 and 2018 at Peking University First Hospital. All the patients underwent imaging on a 1.5 Tesla or 3.0 Tesla MRI scanner. Fifty-six patients met the inclusion criteria. Preoperative imaging was reviewed by two radiologists blinded to details of the patient's surgical procedure and histopathology. Two radiologists measured the maximum anterior-posterior diameter and coronal diameters of the IVC and renal vein, and the craniocaudal extent of tumor thrombus, and evaluated the MRI features of IVC thrombus, including occlusion of the IVC lumen, the margin of the tumor thrombus (smooth vs. irregular), contact of the IVC thrombus and IVC wall, and altered signal of the IVC wall. Univariable and multivariable associations of clinical and radiographic features with IVC wall invasion were evaluated by Logistic regression.
RESULTS: Of the 56 patients [male: 43, female: 13, mean age: (55.64±0.43) years], 17 (30.36%) were detected with IVC wall invasion, and most were clear cell carcinoma. Tumor thrombus with IVC wall invasion showed an increase in length of IVC thrombus [(7.91±3.59) cm vs. (5.94±3.57) cm, P=0.049], and more features of complete occlusion of the IVC lumen (P=0.002), irregular margin of the IVC thrombs (P=0.005), contact of the IVC thrombus and IVC wall (P=0.001), and altered signal of the low-intensity vessel wall (P<0.001), with a sensitivity of 94.12% and a specificity of 79.49%.
CONCLUSION: The present study indicates that MRI could be a means of evaluating RCC with IVC wall invasion, and the combination of tumor thrombus length and subjective impression of IVC wall invasion achieved a high sensitivity and specificity for diagnosis.

Entities:  

Mesh:

Year:  2019        PMID: 31420620      PMCID: PMC7433477          DOI: 10.19723/j.issn.1671-167X.2019.04.013

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  22 in total

Review 1.  Multidetector computed tomography vs magnetic resonance imaging for defining the upper limit of tumour thrombus in renal cell carcinoma: a study and review.

Authors:  Nathan Lawrentschuk; Johan Gani; Richard Riordan; Steven Esler; Damien M Bolton
Journal:  BJU Int       Date:  2005-08       Impact factor: 5.588

2.  Preoperative staging of renal cell carcinoma with inferior vena cava thrombus using multidetector CT and MRI: prospective study with histopathological correlation.

Authors:  Peter J Hallscheidt; Christian Fink; Axel Haferkamp; Michael Bock; Ante Luburic; Ivan Zuna; Gerd Noeldge; Guenter Kauffmann
Journal:  J Comput Assist Tomogr       Date:  2005 Jan-Feb       Impact factor: 1.826

3.  Clinical and radiographic predictors of the need for inferior vena cava resection during nephrectomy for patients with renal cell carcinoma and caval tumour thrombus.

Authors:  Sarah P Psutka; Stephen A Boorjian; Robert H Thompson; Grant D Schmit; John J Schmitz; Thomas C Bower; Suzanne B Stewart; Christine M Lohse; John C Cheville; Bradley C Leibovich
Journal:  BJU Int       Date:  2015-03-23       Impact factor: 5.588

Review 4.  Imaging primary and secondary tumor thrombus of the inferior vena cava: multi-detector computed tomography and magnetic resonance imaging.

Authors:  Carlos Cuevas; Molly Raske; William H Bush; Thomas Takayama; Jeffrey H Maki; Orpheus Kolokythas; Emily Meshberg
Journal:  Curr Probl Diagn Radiol       Date:  2006 May-Jun

5.  Assessment of tumor invasion of the vena caval wall in renal cell carcinoma cases by magnetic resonance imaging.

Authors:  S A Aslam Sohaib; James Teh; Vinod H Nargund; John S P Lumley; William F Hendry; Rodney H Reznek
Journal:  J Urol       Date:  2002-03       Impact factor: 7.450

6.  Magnetic resonance imaging of renal carcinoma with extension into the vena cava: staging accuracy and recent advances.

Authors:  L Myneni; H Hricak; P R Carroll
Journal:  Br J Urol       Date:  1991-12

7.  Impact of imaging and thrombus level in management of renal cell carcinoma extending to veins.

Authors:  Narmada P Gupta; M S Ansari; Anurag Khaitan; M S Sivaramakrishna; Ashok K Hemal; P N Dogra; A Seth
Journal:  Urol Int       Date:  2004       Impact factor: 2.089

8.  Prognostic benefit of surgical management in renal cell carcinoma patients with thrombus extending to the renal vein and inferior vena cava: 17-year experience at a single center.

Authors:  Shingo Hatakeyama; Takahiro Yoneyama; Itsuto Hamano; Hiromi Murasawa; Takuma Narita; Masaaki Oikawa; Kazuhisa Hagiwara; Daisuke Noro; Toshikazu Tanaka; Yoshimi Tanaka; Yasuhiro Hashimoto; Takuya Koie; Chikara Ohyama
Journal:  BMC Urol       Date:  2013-10-14       Impact factor: 2.264

9.  Clinical and oncological outcomes in Chinese patients with renal cell carcinoma and venous tumor thrombus extension: single-center experience.

Authors:  Xiaonan Chen; Shijie Li; Zhenqun Xu; Kefeng Wang; Donghui Fu; Qiang Liu; Xia Wang; Bin Wu
Journal:  World J Surg Oncol       Date:  2015-02-04       Impact factor: 2.754

10.  Renal cell carcinoma with venous extension: prediction of inferior vena cava wall invasion by MRI.

Authors:  Lisa C Adams; Bernhard Ralla; Yi-Na Y Bender; Keno Bressem; Bernd Hamm; Jonas Busch; Florian Fuller; Marcus R Makowski
Journal:  Cancer Imaging       Date:  2018-05-03       Impact factor: 3.909

View more
  1 in total

1.  Preoperative Prediction of Inferior Vena Cava Wall Invasion of Tumor Thrombus in Renal Cell Carcinoma: Radiomics Models Based on Magnetic Resonance Imaging.

Authors:  Zhaonan Sun; Yingpu Cui; Chunru Xu; Yanfei Yu; Chao Han; Xiang Liu; Zhiyong Lin; Xiangpeng Wang; Changxin Li; Xiaodong Zhang; Xiaoying Wang
Journal:  Front Oncol       Date:  2022-06-06       Impact factor: 5.738

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.